SPRO - Spero Therapeutics Q4 2023 Earnings Preview
2024-03-12 17:35:56 ET
More on Spero Therapeutics
- Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M
- Seeking Alpha’s Quant Rating on Spero Therapeutics
- Historical earnings data for Spero Therapeutics
- Financial information for Spero Therapeutics